Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Tormey

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Cancer|April 1, 1976
Mediastinoscopy: a diagnostic aid in metastatic carcinoma of the breastJ P Neifeld, J N Ingle, D C Tormey, et al.
American Journal of Clinical Oncology|December 1, 1995
Phase III study comparing vincristine, doxorubicin (Adriamycin), and dexamethasone (VAD) chemotherapy with VAD plus recombinant interferon alfa-2 in refractory or relapsed multiple myeloma. An Eastern Cooperative Oncology Group studyM A Gertz, L A Kalish, R A Kyle, et al.
Cancer Clinical Trials|January 1, 1981
Vindesine. A phase II trial in advanced breast cancer patientsH I Robins, D C Tormey, M J Skelley, et al.
Breast Cancer Research and Treatment|December 1, 1988
Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two yearsR R Love, R B Mazess, D C Tormey, et al.
Cancer|May 1, 1978
A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breastK B Woo, T P Waalkes, D L Ahmann, et al.
Cancer|June 15, 1986
Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoidsA Y Chang, J P Kuebler, K J Pandya, et al.
Cancer|April 1, 1975
Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosidesD C Tormey, T P Waalkes, D Ahmann, et al.
Cancer|January 15, 1986
Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusionJ M Koeller, D L Trump, K D Tutsch, et al.
Cancer|May 1, 1978
Biologic markers in breast carcinoma. IV. Serum fucose-protein ratio. Comparisons with carcinoembryonic antigen and human chorionic gonadotrophinT P Waalkes, C W Gehrke, D C Tormey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancerC L Loprinzi, D C Tormey, P Rasmussen, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Cancer|April 1, 1976
Mediastinoscopy: a diagnostic aid in metastatic carcinoma of the breastJ P Neifeld, J N Ingle, D C Tormey, et al.
American Journal of Clinical Oncology|December 1, 1995
Phase III study comparing vincristine, doxorubicin (Adriamycin), and dexamethasone (VAD) chemotherapy with VAD plus recombinant interferon alfa-2 in refractory or relapsed multiple myeloma. An Eastern Cooperative Oncology Group studyM A Gertz, L A Kalish, R A Kyle, et al.
Cancer Clinical Trials|January 1, 1981
Vindesine. A phase II trial in advanced breast cancer patientsH I Robins, D C Tormey, M J Skelley, et al.
Breast Cancer Research and Treatment|December 1, 1988
Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two yearsR R Love, R B Mazess, D C Tormey, et al.
Cancer|May 1, 1978
A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breastK B Woo, T P Waalkes, D L Ahmann, et al.
Cancer|June 15, 1986
Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoidsA Y Chang, J P Kuebler, K J Pandya, et al.
Cancer|April 1, 1975
Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosidesD C Tormey, T P Waalkes, D Ahmann, et al.
Cancer|January 15, 1986
Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusionJ M Koeller, D L Trump, K D Tutsch, et al.
Cancer|May 1, 1978
Biologic markers in breast carcinoma. IV. Serum fucose-protein ratio. Comparisons with carcinoembryonic antigen and human chorionic gonadotrophinT P Waalkes, C W Gehrke, D C Tormey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancerC L Loprinzi, D C Tormey, P Rasmussen, et al.
Pageof 14